HDAC6 inhibition reverses long-term doxorubicin-induced cognitive dysfunction by restoring microglia homeostasis and synaptic integrity is a research paper published in Theranostics (2021). On theSindex it has a DataRank of 0. It has been cited 47 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
NCI NIH HHS
Grant: R01 CA230512
NINDS NIH HHS
Grant: R01 NS073939
NCI NIH HHS
Grant: R01 CA208371
NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: R01 CA227064
National Institutes of Health
Grant: 5R01CA227064-05
PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 5R01CA208371-05
Mesenchymal Stem Cells to Repair Chemobrain
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals